海外の治験の状況「濾胞性リンパ腫」での検索結果
82件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not Recruiting
- A Study Comparing MK-8808 to MabThera™ in Patients with Advanced Follicular Lymphoma.
- Previously untreated patients with CD20-positive follicular lymphoma, Grade 1, 2 or 3a according to the WHO 2008 classification system. MedDRA version: 14.1 Level: LLT Classification code 10059432 Term: Follicular mixed small and large cell lymphoma System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Australia, Belarus, Brazil, Canada, Chile, China, Croatia, Egypt, Georgia, India, Israel, Italy, Korea, Republic of, Malaysia, Mexico, New Zealand, Peru, Philippines, Russian Federation, Singapore, South Africa, Taiwan, Thailand, Ukraine
- 2013-01-11
Not recruiting
- Study of Duvelisib in Combination With Rituximab vs Rituximab in Subjects With Previously Treated Follicular Lymphoma
- Follicular Lymphoma;Follicular Lymphoma;Follicular Lymphoma
- Australia, Austria, Belgium, Canada, Czech Republic, Denmark, France, Germany, Hungary, Israel, Italy, New Zealand, Poland, Spain, United Kingdom, United States
- 2014-07-25
Not Recruiting
- A study to identify the most effective dose of Betalutin in patients with a type of follicular lymphoma that is CD37-positive which has recurred
- Relapsed CD37+ non-Hodgkin B-cell follicular lymphoma br>MedDRA version: 18.0 Level: PT Classification code 10029547 Term: Non-Hodgkin's lymphoma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 18.0 Level: PT Classification code 10003902 Term: B-cell lymphoma recurrent System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Austria, Belgium, Canada, Czech Republic, Denmark, France, Germany, Hungary, Israel, Italy, Netherlands, Norway, Poland, Russian Federation, Spain, Sweden, Turkey, United Kingdom, United States
- 2015-07-07
Recruiting
- A study comparing PF-05280586 to MabThera® (rituximab) in patients with follicular lymphoma who have not received previous treatment.
- CD20-positive, low tumor burden, Follicular Lymphoma
- Austria, Belarus, Belgium, Brazil, Canada, Croatia, Egypt, France, Germany, Greece, India, Italy, Japan, Lebanon, Mexico, Other, Peru, Philippines, Poland, Portugal, Republic of Korea, Romania, Russian Federation, South Africa, Spain, Switzerland, Thailand, Turkey, Ukraine, United Kingdom, United States of America
- 2015-05-26
Not Recruiting
- A study of GP2013 in the Treatment of Patients With Previously Untreated, Advanced Stage Follicular Lymphoma (a type of cancer)
- Advanced Stage Follicular Lymphoma
- Argentina, Australia, Austria, Brazil, Bulgaria, Colombia, France, Germany, Greece, Hungary, India, Ireland, Israel, Italy, Japan, Malaysia, Netherlands, New Zealand, Peru, Poland, Portugal, Romania, Russian Federation, South Africa, Spain, Ukraine
- 2012-04-19
Recruiting
- Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma
- Treatment Naive Follicular Lymphoma
- Australia, Austria, Belgium, Canada, Czechia, France, Greece, Hungary, Israel, Italy, Netherlands, New Zealand, Poland, Portugal, Russian Federation, Spain, Taiwan, Turkey, United Kingdom, United States
- 2016-10-26
Recruiting
- Safety Profile of Idelalisib in Patients With Refractory Follicular Lymphoma
- Follicular Non-Hodgkin's Lymphoma Refractory
- Austria, Belgium, France, Germany, Greece, Ireland, Italy, Portugal, Spain, United Kingdom
- 2018-06-14
Not recruiting
- GP2013 in the Treatment of Patients With Previously Untreated, Advanced Stage Follicular Lymphoma
- Follicular Lymphoma
- Argentina, Australia, Austria, Brazil, Bulgaria, Colombia, France, Germany, Greece, Hungary, India, Ireland, Israel, Italy, Japan, Malaysia, Netherlands, Peru, Poland, Portugal, Romania, Russian Federation, South Africa, Spain, Ukraine, United Kingdom
- 2011-08-17
Authorised
- A Phase 2 Study combining BGB-3111 with Obinutuzumab compared with Obinutuzumab Monotherapy in Relapsed/Refractory Follicular Lymphoma
- Relapsed/Refractory Follicular Lymphoma br>MedDRA version: 20.0 Level: HLT Classification code 10016903 Term: Follicle centre lymphomas, follicular grade I, II, III System Organ Class: 100000004851 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Belarus, Bulgaria, Canada, Czech Republic, France, Germany, Hungary, Italy, Korea, Republic of, New Zealand, Poland, Spain, Sweden, Taiwan, United Kingdom, United States
- 2017-10-25
Recruiting
- Rituximab With or Without Ibrutinib for Patients With Advanced Follicular Lymphoma
- Follicular Lymphoma
- Austria, Denmark, Finland, Norway, Sweden, Switzerland
- 2015-05-19
